632 related articles for article (PubMed ID: 16479246)
21. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
Roelants V; Nayer PD; Bouckaert A; Beckers C
Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation.
Alam MS; Kasagi K; Misaki T; Miyamoto S; Iwata M; Iida Y; Konishi J
Thyroid; 1998 Dec; 8(12):1091-100. PubMed ID: 9920363
[TBL] [Abstract][Full Text] [Related]
23. The Value of
Okudan B; Seven B; Gülaldı NCM; Çapraz M; Açıkgöz Y
Curr Med Imaging; 2022; 18(4):404-408. PubMed ID: 34749623
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
25. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
26. [Contribution of computed tomography in patients with lung metastases of differentiated thyroid carcinoma not apparent on plain radiography who were treated with radioiodine].
Rosário PW; Tavares WC; Barroso AL; Rezende LL; Padrão EL; Purisch S
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):114-9. PubMed ID: 18345404
[TBL] [Abstract][Full Text] [Related]
27. Use of
Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
[TBL] [Abstract][Full Text] [Related]
28. Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.
Qiu L; Tan H; Yin H; Zhou J; Cheng D; Shi H
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):313-320. PubMed ID: 30221907
[TBL] [Abstract][Full Text] [Related]
29. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups.
Zakani A; Saghari M; Eftekhari M; Fard-Esfahani A; Fallahi B; Esmaili J; Assadi M
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1215-21. PubMed ID: 22165686
[TBL] [Abstract][Full Text] [Related]
31. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
Biscontini G; Possa M; Sara R; Milella M; Rossetti C
Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
[TBL] [Abstract][Full Text] [Related]
33. Clinical Value of
Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
[TBL] [Abstract][Full Text] [Related]
34. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Hsu CH; Liu FY; Yen RF; Kao CH
Endocr Res; 2003 Feb; 29(1):9-15. PubMed ID: 12665314
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
Nagamachi S; Jinnouchi S; Nishii R; Flores LG; Nakahara H; Futami S; Tamura S; Toshimori H; Kawai K
Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
[TBL] [Abstract][Full Text] [Related]
36. Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
Leboulleux S; El Bez I; Borget I; Elleuch M; Déandreis D; Al Ghuzlan A; Chougnet C; Bidault F; Mirghani H; Lumbroso J; Hartl D; Baudin E; Schlumberger M
Thyroid; 2012 Aug; 22(8):832-8. PubMed ID: 22853728
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer.
Ahn BC; Lee SW; Lee J; Kim C
Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768
[TBL] [Abstract][Full Text] [Related]
38. Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.
Pace L; Klain M; Albanese C; Salvatore B; Storto G; Soricelli A; Salvatore M
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):179-83. PubMed ID: 16205897
[TBL] [Abstract][Full Text] [Related]
39. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
40. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
